View in EDS HTML Full Text PDF Full Text

MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.

Saved in:

Bibliographic Details
Title:	MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.
Authors:	Li, Hui^1,2 (AUTHOR), Hong, Lingzhi^1,2 (AUTHOR), Rocha, Pedro^3,4 (AUTHOR), Bach, Rafael^3,4 (AUTHOR), Solis Soto, Luisa M.⁵ (AUTHOR), Rinsurongkawong, Waree^1,6 (AUTHOR), Zhang, Bingnan^1,7 (AUTHOR), Araujo, Haniel A.^1,8 (AUTHOR), Elamin, Yasir Y.^1,9 (AUTHOR), Altan, Mehmet^1,10 (AUTHOR), Arrechedera, Claudio A.^5,11 (AUTHOR), Zhou, Jianling^1,6 (AUTHOR), Khan, Khaja B.^2,5 (AUTHOR), Lu, Wei^3,5 (AUTHOR), Young, Elliana^4,7 (AUTHOR), Gay, Carl M.^1,5 (AUTHOR), Cascone, Tina^1,6 (AUTHOR), Byers, Lauren A.^1,7 (AUTHOR), Skoulidis, Ferdinandos^1,8 (AUTHOR), Blumenschein, George^1,9 (AUTHOR)
Source:	Cancers. Dec2025, Vol. 17 Issue 23, p3801. 13p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	20726694
DOI:	10.3390/cancers17233801